Portal Hypertension Reversibility with Treatment of Underlying Liver Disease
作者： Paul Y. Kwo , Marco A. Lacerdo
DOI: 10.1007/S11901-015-0275-5
关键词: Medicine 、 Nonalcoholic fatty liver disease 、 Alcoholic liver disease 、 Liver disease 、 Hepatology 、 Gastroenterology 、 Portal hypertension 、 Hepatitis C 、 Internal medicine 、 Cirrhosis 、 Hepatitis B
摘要: Cirrhosis is the end-stage manifestation of chronic hepatitis with most common causes in developed countries being related to B, C, nonalcoholic fatty liver disease (NAFLD), and alcoholic disease. With more advanced cirrhosis, development portal hypertension occurs that leads clinical decompensation. improvement therapies for B we have seen regression fibrosis even cirrhosis. However, there are limited data on reversal hypertension. This review examines direct indirect evidence will be able see those
springer.com
sci-hub.se 参考文章(24)
Vincent Mallet, Hélène Gilgenkrantz, Jeanne Serpaggi, Virginie Verkarre, Anaïs Vallet-Pichard, Hélène Fontaine, Stanislas Pol, Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C Annals of Internal Medicine. ,vol. 149, pp. 399- 403 ,(2008) , 10.7326/0003-4819-149-6-200809160-00006
Lisa M. Forman, James D. Lewis, Jesse A. Berlin, Harold I. Feldman, Michael R. Lucey, The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology. ,vol. 122, pp. 889- 896 ,(2002) , 10.1053/GAST.2002.32418
Reiner Wiest, Guadalupe Garcia-Tsao, Bacterial translocation (BT) in cirrhosis. Hepatology. ,vol. 41, pp. 422- 433 ,(2005) , 10.1002/HEP.20632
Eugene R. Schiff, Ching-Lung Lai, Stefanos Hadziyannis, Peter Neuhaus, Norah Terrault, Massimo Colombo, Hans L. Tillmann, Didier Samuel, Stefan Zeuzem, Leslie Lilly, Maria Rendina, Jean-Pierre Villeneuve, Nicole Lama, Craig James, Michael S. Wulfsohn, Hamid Namini, Christopher Westland, Shelly Xiong, Gavin S. Choy, Sally Van Doren, John Fry, Carol L. Brosgart, Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre– and post–liver transplantation patients Hepatology. ,vol. 38, pp. 1419- 1427 ,(2003) , 10.1016/J.HEP.2003.09.040
M. Manns, X. Forns, D. Samuel, J. Denning, S. Arterburn, T. Brandt-Sarif, H. Dvory-Sobol, P.S. Pang, J.G. McHutchison, E. Gane, D. Mutimer, G02 : Ledipasvir/sofosbuvir with ribavirin is safe and efficacious in decompensated and post liver transplantation patients with HCV infection: Preliminary results of the prospective solar 2 trial Journal of Hepatology. ,vol. 62, ,(2015) , 10.1016/S0168-8278(15)30003-9
Morris Sherman, Ian R. Wanless, Eisuke Nakashima, Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Archives of Pathology & Laboratory Medicine. ,vol. 124, pp. 1599- 1607 ,(2000) , 10.1043/0003-9985(2000)124<1599:ROHC>2.0.CO;2
RJ Fontana, EA Hughes, M Bifano, H Appelman, D Dimitrova, R Hindes, WT Symonds, None, Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C. American Journal of Transplantation. ,vol. 13, pp. 1601- 1605 ,(2013) , 10.1111/AJT.12209
Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis, Robert S. Brown, Michael W. Fried, Norah A. Terrault, Jacqueline G. O'Leary, Hugo E. Vargas, Alexander Kuo, Eugene Schiff, Mark S. Sulkowski, Richard Gilroy, Kymberly D. Watt, Kimberly Brown, Paul Kwo, Surakit Pungpapong, Kevin M. Korenblat, Andrew J. Muir, Lewis Teperman, Robert J. Fontana, Jill Denning, Sarah Arterburn, Hadas Dvory-Sobol, Theo Brandt-Sarif, Phillip S. Pang, John G. McHutchison, K. Rajender Reddy, Nezam Afdhal, Princy Kumar, Eugene Schiff, Nezam Afdhal, Robert S. Brown, Michael Fried, Kris Kowdley, Norah Terrault, Michael Charlton, Paul Kwo, Steve Flamm, John Lake, Greg Everson, Mark Sulkowski, Michael Curry, Rajender Reddy, Lewis Teperman, Hugo Vargas, Surakit Pungpapong, Andrew Muir, Atif Zaman, Kimberly Brown, Charles Landis, Alexander Kuo, Robert Fontana, Jacqueline O'Leary, Richard Gilroy, Obaid Shaikh, Kevin Korenblat, Richard Stravitz, Kymberly Watt, Narayanan Menon, James Bredfeldt, Carlos Romero-Marrero, Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease Gastroenterology. ,vol. 149, pp. 649- 659 ,(2015) , 10.1053/J.GASTRO.2015.05.010
Xavier Forns, Michael Charlton, Jill Denning, John G McHutchison, William T Symonds, Diana Brainard, Theo Brandt‐Sarif, Paul Chang, Valerie Kivett, Lluís Castells, Martín Prieto, Robert J Fontana, Thomas F Baumert, Audrey Coilly, Maria Carlota Londoño, François Habersetzer, None, Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation Hepatology. ,vol. 61, pp. 1485- 1494 ,(2015) , 10.1002/HEP.27681
Morris Sherman, Ian R. Wanless, Eisuke Nakashima, Regression of Human Cirrhosis Archives of Pathology & Laboratory Medicine. ,vol. 124, pp. 1599- 1607 ,(2000) , 10.5858/2000-124-1599-ROHC